6-127287125-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001242850.2(RNF146):āc.512T>Cā(p.Ile171Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00011 in 1,613,262 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00011 ( 0 hom., cov: 31)
Exomes š: 0.00011 ( 0 hom. )
Consequence
RNF146
NM_001242850.2 missense
NM_001242850.2 missense
Scores
2
3
14
Clinical Significance
Conservation
PhyloP100: 6.01
Genes affected
RNF146 (HGNC:21336): (ring finger protein 146) Enables poly-ADP-D-ribose binding activity and ubiquitin-protein transferase activity. Involved in positive regulation of canonical Wnt signaling pathway; protein ubiquitination; and ubiquitin-dependent protein catabolic process. Located in cytosol; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.065362185).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNF146 | NM_001242850.2 | c.512T>C | p.Ile171Thr | missense_variant | 3/3 | ENST00000368314.6 | NP_001229779.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNF146 | ENST00000368314.6 | c.512T>C | p.Ile171Thr | missense_variant | 3/3 | 2 | NM_001242850.2 | ENSP00000357297 | A1 | |
RNF146 | ENST00000610153.1 | c.512T>C | p.Ile171Thr | missense_variant | 3/3 | 2 | ENSP00000476814 | A1 | ||
RNF146 | ENST00000608991.5 | c.509T>C | p.Ile170Thr | missense_variant | 5/5 | 4 | ENSP00000477168 | P4 | ||
RNF146 | ENST00000356799.6 | c.*517T>C | 3_prime_UTR_variant | 4/4 | 2 | ENSP00000349253 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151896Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
17
AN:
151896
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000144 AC: 36AN: 249916Hom.: 0 AF XY: 0.0000962 AC XY: 13AN XY: 135072
GnomAD3 exomes
AF:
AC:
36
AN:
249916
Hom.:
AF XY:
AC XY:
13
AN XY:
135072
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000109 AC: 160AN: 1461248Hom.: 0 Cov.: 32 AF XY: 0.0000977 AC XY: 71AN XY: 726934
GnomAD4 exome
AF:
AC:
160
AN:
1461248
Hom.:
Cov.:
32
AF XY:
AC XY:
71
AN XY:
726934
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 152014Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74302
GnomAD4 genome
AF:
AC:
17
AN:
152014
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
74302
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
11
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2024 | The c.512T>C (p.I171T) alteration is located in exon 3 (coding exon 2) of the RNF146 gene. This alteration results from a T to C substitution at nucleotide position 512, causing the isoleucine (I) at amino acid position 171 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T;T;.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D;.;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.;L;.
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.;N;.;.
REVEL
Benign
Sift
Benign
T;.;T;.;.
Sift4G
Benign
.;.;T;.;T
Polyphen
B;B;.;B;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at